Cargando…

Spontaneous apoptosis in ovarian carcinomas: a positive association with p53 gene mutation is dependent on growth fraction

Changes in cell survival contribute to tumour development, influence tumour biology and its response to chemotherapy. p53 gene alterations should negatively affect apoptosis by impaired p53-dependent apoptotic response. We looked for associations between spontaneous apoptosis, p53 gene mutation, p53...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kupryjánczyk, J, Dansonka-Mieszkowska, A, Szymánska, T, Karpínska, G, Rembiszewska, A, Rusin, M, Konopínski, R, Kraszewska, E, Timorek, A, Yandell, D W, Stelmachów, J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363315/ https://www.ncbi.nlm.nih.gov/pubmed/10682669 http://dx.doi.org/10.1054/bjoc.1999.0967

Ejemplares similares

TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
por: Kupryjanczyk, Jolanta, et al.
Publicado: (2008)

Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen
por: Kupryjańczyk, J, et al.
Publicado: (2003)

TP53 status determines clinical significance of ERBB2 expression in ovarian cancer
por: Kupryjańczyk, J, et al.
Publicado: (2004)

The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome
por: Konopka, Bozena, et al.
Publicado: (2016)

A novel germline PALB2 deletion in Polish breast and ovarian cancer patients
por: Dansonka-Mieszkowska, Agnieszka, et al.
Publicado: (2010)

Cyclooxygenase-2 immunohistochemical expression in serrated polyps of the colon
por: Kiedrowski, Miroslaw, et al.
Publicado: (2014)

Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2019)

Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2015)

Unsupervised analysis reveals two molecular subgroups of serous ovarian cancer with distinct gene expression profiles and survival
por: Lisowska, Katarzyna M., et al.
Publicado: (2016)

Telomerase activity and p53-dependent apoptosis in ovarian cancer cells
por: Akeshima, R, et al.
Publicado: (2001)

Spontaneous and inducible apoptosis in oesophageal adenocarcinoma
por: Raouf, A, et al.
Publicado: (2001)

Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
por: Felisiak-Golabek, Anna, et al.
Publicado: (2011)

p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer
por: Ferrandina, G, et al.
Publicado: (1999)

The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients
por: Szafron, Lukasz Michal, et al.
Publicado: (2015)

Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer
por: Dansonka-Mieszkowska, Agnieszka, et al.
Publicado: (2018)

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
por: Tannapfel, A, et al.
Publicado: (1999)

PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients
por: Dansonka-Mieszkowska, Agnieszka, et al.
Publicado: (2022)

HAX-1 overexpression, splicing and cellular localization in tumors
por: Trebinska, Alicja, et al.
Publicado: (2010)

Extracellular Matrix Survival Signals Transduced by Focal Adhesion Kinase Suppress p53-mediated Apoptosis
por: Ilić, Duško, et al.
Publicado: (1998)

p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer
por: Anttila, M A, et al.
Publicado: (1999)

Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells
por: Pruschy, M, et al.
Publicado: (1999)

Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass
por: Vogl, F D, et al.
Publicado: (2000)

Mitigation of apoptosis-mediated neurotoxicity induced by silver nanoparticles via rutaceae nutraceuticals: P53 activation and Bax/Bcl-2 regulation
por: Abdel-Megeed, Rehab M., et al.
Publicado: (2022)

Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations
por: Wang-Gohrke, S, et al.
Publicado: (1999)

Hexane fraction of Globimetula braunii induces mitochondria-mediated apoptosis in Plasmodium berghei-infected mice
por: Olanlokun, John Oludele, et al.
Publicado: (2022)

SCGB3A2 Inhibits Acrolein-Induced Apoptosis through Decreased p53 Phosphorylation
por: Kurotani, Reiko, et al.
Publicado: (2015)

Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer
por: Borner, M M, et al.
Publicado: (1999)

Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer
por: Tanaka, F, et al.
Publicado: (2001)

Retinoblastoma protein-initiated cellular growth arrest overcomes the ability of cotransfected wild-type p53 to induce apoptosis
por: Shinohara, H, et al.
Publicado: (2000)

Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts
por: Kolfschoten, G M, et al.
Publicado: (2000)

Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status
por: Brodowicz, T, et al.
Publicado: (2001)

Expressions of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms
por: Munakata*, S, et al.
Publicado: (2000)

Evaluating effect of acrylamide and ascorbic acid on oxidative stress and apoptosis in ovarian tissue of wistar rat
por: Firouzabadi, Amir Masoud, et al.
Publicado: (2022)

Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2
por: Schuyer, M, et al.
Publicado: (2001)

Glycerol restores p53-dependent radiosensitivity of human head and neck cancer cells bearing mutant p53
por: Ohnishi, K, et al.
Publicado: (2000)

The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues
por: Szafron, Lukasz Michal, et al.
Publicado: (2015)

Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies
por: Moch, C, et al.
Publicado: (2001)

Procalcitonin and C-reactive protein-based decision tree model for distinguishing PFAPA flares from acute infections
por: Kraszewska-Głomba, Barbara, et al.
Publicado: (2016)

A decision tree based on procalcitonin and C-reactive protein levels as a potential diagnostic tool to distinguish PFAPA flares from acute bacterial and viral infections
por: Kraszewska-Glomba, B, et al.
Publicado: (2015)

p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer
por: Schneider, J, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_4rbjl2mkb1m69ohfnnt4g073br